Effect of CO 2  concentration on intermediates of the Embden-Myerhof pathway and the citric acid cycle in isolated perfused rat liver.
D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002245:Carbon Dioxide / Q000494:pharmacology*; D002951:Citrates / Q000378:metabolism; D002952:Citric Acid Cycle / Q000187:drug effects*; D005260:Female; D005632:Fructose / Q000378:metabolism; D005947:Glucose / Q000032:analysis / Q000378:metabolism; D005990:Glycerol / Q000032:analysis / Q000378:metabolism; D005994:Glycerophosphates / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006600:Hexosephosphates / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008293:Malates / Q000378:metabolism; D008297:Male; D010477:Perfusion; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D002951:Citrates; D005994:Glycerophosphates; D006600:Hexosephosphates; D008293:Malates; D011773:Pyruvates; D002245:Carbon Dioxide; D005632:Fructose; D001224:Aspartic Acid; D005947:Glucose; D005990:Glycerol